PF-AtlasDrugs › HRCT

HRCT

Idiopathic Pulmonary Fibrosis

Clinical trials
1
Developer
University of Virginia

Overview

HRCT is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.

HRCT clinical trials

Explore related

Medical disclaimer. This page summarizes research about HRCT for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.